143 related articles for article (PubMed ID: 870516)
1. Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay.
Chochinov RH; Mariz IK; Hajek AS; Daughaday WH
J Clin Endocrinol Metab; 1977 May; 44(5):902-8. PubMed ID: 870516
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors.
Chochinov RH; Mariz IK; Daughaday WH
Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631
[TBL] [Abstract][Full Text] [Related]
3. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.
Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay.
Drop SL; Kortleve DJ; Guyda HJ
J Clin Endocrinol Metab; 1984 Nov; 59(5):899-907. PubMed ID: 6207199
[TBL] [Abstract][Full Text] [Related]
5. Comparison of [125I]somatomedin A and [125I]somatomedin C radioreceptor assays for somatomedin peptide content in whole and acid-chromatographed plasma.
Horner JM; Liu F; Hintz RL
J Clin Endocrinol Metab; 1978 Dec; 47(6):1287-95. PubMed ID: 263658
[TBL] [Abstract][Full Text] [Related]
6. Purification and biologic properties of fibroblast somatomedin.
Clemmons DR; Shaw DS
J Biol Chem; 1986 Aug; 261(22):10293-8. PubMed ID: 2426261
[TBL] [Abstract][Full Text] [Related]
7. Partial characterization of somatomedin bioactivity in term human amniotic fluid.
Bala RM; Smith GR
J Clin Endocrinol Metab; 1976 Oct; 43(4):907-12. PubMed ID: 977727
[TBL] [Abstract][Full Text] [Related]
8. Amniotic fluid reactivity detected by somatomedin C radioreceptor assay: correlation with growth hormone, prolactin and fetal renal maturation.
Chochinov RH; Ketupanya A; Mariz IK; Underwood LE; Daughaday WH
J Clin Endocrinol Metab; 1976 May; 42(5):983-6. PubMed ID: 1270588
[TBL] [Abstract][Full Text] [Related]
9. Partial characterization of a somatomedin-like peptide from the medium of cultured rat Sertoli cells.
Smith EP; Svoboda ME; Van Wyk JJ; Kierszenbaum AL; Tres LL
Endocrinology; 1987 Jan; 120(1):186-93. PubMed ID: 2946573
[TBL] [Abstract][Full Text] [Related]
10. Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV.
Blum WF; Ranke MB; Bierich JR
Acta Endocrinol (Copenh); 1986 Feb; 111(2):271-84. PubMed ID: 3953237
[TBL] [Abstract][Full Text] [Related]
11. Somatomedin bioactivity in serum and amniotic fluid during pregnancy.
Bala RM; Wright C; Bardai A; Smith GR
J Clin Endocrinol Metab; 1978 Apr; 46(4):649-52. PubMed ID: 755049
[TBL] [Abstract][Full Text] [Related]
12. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid.
Koistinen R; Kalkkinen N; Huhtala ML; Seppälä M; Bohn H; Rutanen EM
Endocrinology; 1986 Apr; 118(4):1375-8. PubMed ID: 2419121
[TBL] [Abstract][Full Text] [Related]
13. Somatomedin-C/insulin-like growth factor I-binding proteins in human amniotic fluid and in fetal and postnatal blood: evidence of immunological homology.
D'Ercole AJ; Drop SL; Kortleve DJ
J Clin Endocrinol Metab; 1985 Oct; 61(4):612-7. PubMed ID: 2411754
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.
Herington AC; Kuffer AD
Biochem J; 1984 Oct; 223(1):89-96. PubMed ID: 6388566
[TBL] [Abstract][Full Text] [Related]
15. Affinity-labeled somatomedin-C receptors and binding proteins from the human fetus.
Grizzard JD; D'Ercole AJ; Wilkins JR; Moats-Staats BM; Williams RW
J Clin Endocrinol Metab; 1984 Mar; 58(3):535-43. PubMed ID: 6198334
[TBL] [Abstract][Full Text] [Related]
16. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.
Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD
Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975
[TBL] [Abstract][Full Text] [Related]
17. Somatomedin inhibitor in uremia.
Phillips LS; Fusco AC; Unterman TG; del Greco F
J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
[TBL] [Abstract][Full Text] [Related]
18. Basic peptide with insulin-like activity in human serum.
Sasaki N; Okabe T; Imai Y; Matsuzaki F; Kosaka K; Wakai K; Tsushima T
Endocrinol Jpn; 1981 Apr; 28(2):157-67. PubMed ID: 7030722
[TBL] [Abstract][Full Text] [Related]
19. Partial characterization of a mitogenic factor with somatomedin-like activity produced by culture WI-38 human fibroblasts.
Atkison PR; Bala RM
J Cell Physiol; 1981 Jun; 107(3):317-27. PubMed ID: 6972946
[TBL] [Abstract][Full Text] [Related]
20. Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties.
Koistinen R; Huhtala ML; Stenman UH; Seppälä M
Clin Chim Acta; 1987 May; 164(3):293-303. PubMed ID: 3109787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
